LC-MS/MS Analysis and Biological Activities of Different Parts of Ziziphora capitata L.


Yiğitkan S., Çavuşoğlu M., Çağlayan M. V., Yener I., Fırat M., Çavuşoğlu Kaya E., ...Daha Fazla

KSU TARIM VE DOGA DERGISI-KSU JOURNAL OF AGRICULTURE AND NATURE, cilt.27, sa.2, ss.307-315, 2024 (ESCI)

Özet

The Ziziphora species, classified under the Lamiaceae family, have a

strong aromatic property. Ziziphora species have been used in folk

medicine as sedative, gastric, aphrodisiac, bloating, and degassing. In the

current study, the phenolic and flavanoid content of ethanol extracts of

Ziziphora capitata L. species of flower, leaf, branch, mixed, and root parts

was determined by the LC-MS/MS device. In addition, the antioxidant

and cytotoxic activities of the extracts, as well as their inhibitory effects

on enzymes (antihypertensive, AchE (acetylcholinesterase), BchE

(butyrylcholinesterase), elastase, tyrosinase, collagenase and urease),

were determined. The LC-MS/MS results showed that quinic acid (25578,

5842, 25171, 14055, 10597 μg g-1, respectively) was found in higher

amounts in flower, leaf, branch, mixed, and root extracts of Z. capitata

species compared to other components. Additionally, rosmarinic acid

(17097 μg g-1), cynaroside (8432), and hesperidin (8067) were found to be

major components. It was observed that the flower extract of the species

exhibited strong antioxidant activity (IC50: 37.18±1.36 μg mL-1, 9.89±0.45,

A0.5:16.27±0.02, respectively) in DPPH, ABTS and CUPRAC methods. It

was concluded that the leaf extract of Z. capitata species had a strong

cytotoxic effect on HT-29 (colon cancer cell line) (viability %: 9.26±0.69).

It was observed that the root part of the species exhibited higher activity

in butyrylcholinesterase (BChE) enzyme inhibition activity (inhibition %:

40.56±0.88) than other parts. It was determined that Z. capitata extracts

did not show acetylcholinesterase, urease, tyrosinase, elastase,

collagenase, and antihypertensive enzyme activity or showed low

activity. As a result, it is thought that the flower extract of the Z. capitata

species has better results in terms of the examined parameters, whereas

the leaf extract needs to be subjected to more detailed in vitro and in vivo

research conducted to be used in the pharmaceutical industry as a result

of its cytotoxic effect against colon cancer cell lines.